Independent Living Research Utilization

This document is a consolidation of acquisition-related questions that have been posed by agencies, contractors, and members of the disability community regarding section 508 of the Rehabilitation Act. The responses to these questions are intended to promote a better understanding of the requirements of section 508 and its implementing regulations, including the collaboration that is anticipated within agencies in the acquisition of EIT. Full version of this document can be found here

Both e-learning and the amended Section 508 of the Rehabilitation Act are at the beginning stages of implementation. This can make the implementation of either difficult to understand for both the program office responsible for e-learning and the contracting office. This paper is written to aid them in their understanding of the issues and processes in purchasing the best e-learning solution while being in compliance with the provisions of Section 508 as amended. Full version of this document can be found here

UFAS are the accessibility standards for Federal and federally-funded facilities. These standards are to be applied during the design, construction, and alteration of buildings and facilities to the extent required by the Architectural Barriers Act of 1968, as amended.

The purpose of this workbook is to enable people to survey buildings for compliance with the Uniform Federal Accessibility Standards (UFAS). UFAS defines environments which are safe, accessible and usable by people of all ages and abilities.

(DOJ) 58 pgs. This 52 page manual was developed by the United States Department of Justice, Civil Rights Division in order to provide technical assistance on the provisions set forth in Title II of the Americans with Disabilities Act.This manual can be found here. Yearly Supplements for Technical Assistance Manual on Title II is located here.

Resistance could lead to breakouts of the infection in communities where it has been brought under control, a Canadian study in the Lancet reports.

Ivermectin, used since the late 1980s, is the only drug available for the mass treatment of river blindness.

Experts warned the findings highlighted the urgent need for new treatments.

River blindness (onchocerciasis) is caused by a nematode worm which is transmitted by a black fly.